| 345 |
Endosulfan
|
-
Endosulfan, CAS-RN: 115-29-7, DTXSID1020560
|
2 AOPs
|
| 350 |
Enflurane
|
-
Enflurane, CAS-RN: 13838-16-9, DTXSID1020562
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 807 |
Enoximone
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 423 |
Entacapone
|
-
Entacapone, CAS-RN: 130929-57-6, DTXSID5046439
|
None
|
| 407 |
Epidermal growth factor
|
-
Epidermal growth factor, CAS-RN: 62229-50-9, DTXSID5040469
|
None
|
| 615 |
epigallocathechin gallate
|
|
None
|
| 796 |
Epinephrine
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 408 |
Epothilone A
|
-
Epothilone A, CAS-RN: 152044-53-6, DTXSID10332288
|
None
|
| 409 |
Epothilone B
|
-
Epothilone B, CAS-RN: 152044-54-7, DTXSID4046862
|
None
|
| 559 |
Epoxiconazole
|
-
Epoxiconazole, CAS-RN: 133855-98-8, DTXSID1040372
|
None
|
| 700 |
Escitalopram
|
-
Escitalopram, CAS-RN: 128196-01-0, DTXSID8048440
|
None
|
| 105 |
Esfenvalerate
|
-
Esfenvalerate, CAS-RN: 66230-04-4, DTXSID4032667
|
None
|
| 452 |
Estrogen
|
|
None
|
| 360 |
Ethanol
|
-
Ethanol, CAS-RN: 64-17-5, DTXSID9020584
|
2 AOPs
|
| 154 |
Ethyl acetate
|
-
Ethyl acetate, CAS-RN: 141-78-6, DTXSID1022001
|
None
|
| 737 |
Ethyl alcohol
|
|
443: DNA damage and mutations leading to Metastatic Breast Cancer
|
| 22 |
Ethyl methanesulfonate
|
-
Ethyl methanesulfonate, CAS-RN: 62-50-0, DTXSID6025309
|
550: Increased LMNA gene mutation leading to heart failure
|
| 23 |
Ethyl nitrosourea
|
-
1-Ethyl-1-nitrosourea, CAS-RN: 759-73-9, DTXSID8020593
|
None
|
| 651 |
Ethyl Parathion
|
|
2 AOPs
|
| 24 |
Ethyl-N'-nitro-N-nitrosoguanidine
|
-
N′-Ethyl-N-nitro-N-nitrosoguanidine, CAS-RN: 63885-23-4, DTXSID3020592
|
None
|
| 25 |
Ethylene thiourea
|
-
Ethylene thiourea, CAS-RN: 96-45-7, DTXSID5020601
|
271: Inhibition of thyroid peroxidase leading to impaired fertility in fish
|
| 56 |
Ethylenethiourea
|
-
Ethylene thiourea, CAS-RN: 96-45-7, DTXSID5020601
|
None
|
| 576 |
Etomidate
|
-
Etomidate, CAS-RN: 33125-97-2, DTXSID5023033
|
349: Inhibition of 11β-hydroxylase leading to decresed population trajectory
|
| 223 |
Etoposide
|
-
Etoposide, CAS-RN: 33419-42-0, DTXSID5023035
|
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 281 |
etoposide quinone
|
|
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|